Whalerock Point Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.25M Buy
14,740
+897
+6% +$487K 1.4% 17
2025
Q4
$8.02M Buy
13,843
+105
+0.8% +$59.4K 1.53% 13
2025
Q3
$6.66M Sell
13,738
-485
-3% -$226K 1.35% 18
2025
Q2
$5.77M Hold
14,223
1.25% 20
2025
Q1
$7.08M Buy
14,223
+730
+5% +$395K 1.68% 15
2024
Q4
$7.02M Buy
13,493
+304
+2% +$167K 1.63% 14
2024
Q3
$8.16M Buy
13,189
+103
+0.8% +$61K 1.94% 11
2024
Q2
$7.24M Buy
13,086
+208
+2% +$119K 1.94% 11
2024
Q1
$7.48M Buy
12,878
+442
+4% +$248K 2.04% 11
2023
Q4
$6.6M Buy
12,436
+67
+0.5% +$32.4K 2.04% 11
2023
Q3
$6.26M Buy
12,369
+633
+5% +$337K 2.17% 11
2023
Q2
$6.12M Buy
11,736
+418
+4% +$226K 2.08% 12
2023
Q1
$6.52M Buy
11,318
+145
+1% +$81.7K 2.42% 7
2022
Q4
$6.15M Buy
11,173
+107
+1% +$56.7K 2.5% 8
2022
Q3
$5.61M Buy
11,066
+103
+0.9% +$57.6K 2.47% 8
2022
Q2
$5.96M Buy
10,963
+10
+0.1% +$5.5K 2.52% 8
2022
Q1
$6.47M Buy
10,953
+465
+4% +$267K 2.29% 11
2021
Q4
$7M Sell
10,488
-65
-0.6% -$40.6K 2.4% 10
2021
Q3
$6.03M Buy
10,553
+55
+0.5% +$30.2K 2.34% 10
2021
Q2
$5.3M Buy
10,498
+35
+0.3% +$16.5K 2.04% 11
2021
Q1
$4.78M Buy
10,463
+661
+7% +$315K 2.1% 12
2020
Q4
$4.57M Buy
9,802
+6,121
+166% +$2.87M 2.17% 10
2020
Q3
$3.68M Sell
3,681
-3,896
-51% -$1.61M 2.03% 12
2020
Q2
$2.75M Buy
7,577
+674
+10% +$226K 1.62% 20
2020
Q1
$1.96M Buy
6,903
+758
+12% +$239K 1.4% 22
2019
Q4
$2M Sell
6,145
-110
-2% -$33.4K 1.06% 29
2019
Q3
$1.82M Buy
6,255
+1,092
+21% +$313K 0.98% 30
2019
Q2
$1.52M Buy
5,163
+36
+0.7% +$9.91K 0.87% 32
2019
Q1
$1.4M Buy
5,127
+1,243
+32% +$309K 0.92% 35
2018
Q4
$869K Buy
3,884
+824
+27% +$193K 0.81% 36
2018
Q3
$747K Buy
3,060
+760
+33% +$175K 0.54% 49
2018
Q2
$476K Sell
2,300
-828
-26% -$176K 0.38% 66
2018
Q1
$646K Buy
3,128
+602
+24% +$126K 0.21% 85
2017
Q4
$480K Buy
2,526
+10
+0.4% +$1.92K 0.15% 109
2017
Q3
$476K Sell
2,516
-350
-12% -$63.4K 0.17% 91
2017
Q2
$500K Buy
2,866
+66
+2% +$11.1K 0.18% 93
2017
Q1
$431K Sell
2,800
-15
-0.5% -$2.29K 0.16% 93
2016
Q4
$398K Buy
2,815
+500
+22% +$73.7K 0.16% 90
2016
Q3
$368K Buy
+2,315
New +$357K 0.15% 96
2016
Q1
$307K Buy
2,170
+75
+4% +$10.1K 0.13% 110
2015
Q4
$297K Buy
+2,095
New +$279K 0.13% 116

Other funds holding TMO

Whalerock Point Partners's TMO Position: Q1 2026 in Review

Whalerock Point Partners increased its Thermo Fisher Scientific (TMO) stake by 6.5% in Q1 2026, buying an estimated $487K and bringing the position to 14,740 shares worth $7.25M. The position accounts for 1.4% of the portfolio, ranked #17.

Whalerock Point Partners first reported a position in TMO in Q4 2015 and has held it in 41 quarters since. The position peaked at $8.16M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Whalerock Point Partners held 14,740 shares of Thermo Fisher Scientific worth $7.25M as of Q1 2026.
  • Whalerock Point Partners bought 897 Thermo Fisher Scientific shares in Q1 2026, an estimated $487K.
  • Thermo Fisher Scientific made up 1.4% of Whalerock Point Partners's portfolio in Q1 2026, its #17 holding.
  • Whalerock Point Partners first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 41 quarters since.
  • Whalerock Point Partners's Thermo Fisher Scientific position peaked at $8.16M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.